Prostaglandin E2: A Potential Link Between NSAIDs and the Menstrual Cycle, Cofactors of Food-Dependent Anaphylaxis
Journal of Investigational Allergology and Clinical Immunology · 2025
DOI: 10.18176/jiaci.1070 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Investigational Allergology and Clinical Immunology, 2025. Verfasst von V Tubita und 4 weiteren Autor:innen. Beteiligte Einrichtung: METRI2A-Institut d´Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain. Hauptthemen laut MEDLINE: Anaphylaxis, Anti-Inflammatory Agents, Non-Steroidal, Dinoprostone, Menstrual Cycle. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Food-induced anaphylaxis presents a significant health risk, accounting for 25% to 50% of adult allergic reactions. The variability in severity, even with identical allergen exposure (dose and allergen), suggests the involvement of other factors (cofactors) in exacerbation of allergic responses. Cofactors may function in 2 ways: by lowering the reaction threshold, ensuring patients remain asymptomatic in the absence of the cofactor and only experience symptoms when it is present; or by increasing severity, enabling patients with mild symptoms to endure a stronger reaction in the presence of the cofactor. Two cofactors have emerged, namely, nonsteroidal anti-inflammatory drugs (NSAIDs), which are well documented, and the menstrual cycle, which has received less attention. However, their intricate interplay has not yet been elucidated. Widely used for their anti-inflammatory properties, NSAIDs disrupt gastrointestinal integrity, reduce synthesis of prostaglandin E2 (PGE2) by inhibiting the enzyme cyclooxygenase (COX), and participate in mast cell activation, thus exacerbating food allergy symptoms. Similarly, the hormonal fluctuations during the menstrual cycle affect the COX pathway, modulating mast cell activation and allergic sensitivities. PGE2, a key mediator in immune modulation, plays a crucial role in maintaining immune homeostasis and suppressing mast cell activation. This review examines the potential role of PGE2 as a plausible link between NSAIDs and menstruation as cofactors in food allergy, suggesting a central role in modulating allergic sensitivities.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- METRI2A-Institut d´Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.
- Universitat de Barcelona, Barcelona, Spain.
- CIBER of Respiratory Diseases (CIBERES), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
- Allergy Department, Hospital Clínic, Barcelona, Spain.
- REI-RICORS, Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Zitieren
APA
Tubita, V., Mir Ihara, P., González-Matamala, M. F., Picado, C., & Muñoz Cano, R. M. (2025). Prostaglandin E2: A Potential Link Between NSAIDs and the Menstrual Cycle, Cofactors of Food-Dependent Anaphylaxis. Journal of Investigational Allergology and Clinical Immunology. https://doi.org/10.18176/jiaci.1070
Vancouver
Tubita V, Mir Ihara P, González-Matamala MF, Picado C, Muñoz Cano RM. Prostaglandin E2: A Potential Link Between NSAIDs and the Menstrual Cycle, Cofactors of Food-Dependent Anaphylaxis. Journal of Investigational Allergology and Clinical Immunology. 2025. doi:10.18176/jiaci.1070
BibTeX
@article{Tubita2025,
author = {Tubita, V and Mir Ihara, P and González-Matamala, M F and Picado, C and Muñoz Cano, R M},
title = {Prostaglandin E2: A Potential Link Between NSAIDs and the Menstrual Cycle, Cofactors of Food-Dependent Anaphylaxis},
journal = {Journal of Investigational Allergology and Clinical Immunology},
year = {2025},
doi = {10.18176/jiaci.1070}
}
EUVIMED